Campbell & CO Investment Adviser LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Campbell & CO Investment Adviser LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$273,267
-47.4%
10,030
-57.0%
0.03%
-64.5%
Q2 2023$519,538
+23.4%
23,350
+20.1%
0.09%
+19.2%
Q1 2023$421,070
-67.7%
19,440
-69.7%
0.08%
-75.0%
Q4 2022$1,302,440
+37.5%
64,128
+73.7%
0.31%
+45.1%
Q3 2022$947,000
+109.1%
36,917
+93.9%
0.22%
+76.2%
Q2 2022$453,000
-62.4%
19,042
-64.4%
0.12%
-62.5%
Q1 2022$1,205,000
+277.7%
53,500
+230.2%
0.32%
+212.5%
Q3 2021$319,000
-0.9%
16,200
+10.6%
0.10%
-21.8%
Q2 2021$322,000
+15.8%
14,650
+25.2%
0.13%
-22.2%
Q1 2021$278,000
-45.8%
11,700
-60.3%
0.17%
-55.2%
Q3 2020$513,000
-34.3%
29,487
-54.3%
0.38%
+59.8%
Q4 2019$781,000
+73.6%
64,508
+176.9%
0.24%
-34.3%
Q3 2017$450,000
+163.2%
23,300
+60.4%
0.36%
+128.9%
Q2 2017$171,000
+6.9%
14,530
-0.6%
0.16%
-61.6%
Q1 2017$160,000
+36.8%
14,613
-9.3%
0.41%
+14.7%
Q4 2016$117,000
-15.8%
16,111
-24.9%
0.36%
-3.5%
Q3 2016$139,000
+61.6%
21,446
+35.8%
0.37%
-14.0%
Q2 2016$86,00015,7940.44%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,340,193$227,22910.94%
Novo Holdings A/S 3,377,768$92,044,1786.80%
Parallel Advisors, LLC 3,723,483$101,446,2943.38%
TANAKA CAPITAL MANAGEMENT INC 37,569$1,0242.92%
S&T BANK/PA 334,252$9,1071.76%
Birchview Capital, LP 50,000$1,362,2501.16%
Granite Investment Partners, LLC 798,552$21,756,5490.91%
FAS Wealth Partners, Inc. 310,764$8,466,7660.90%
Clearview Wealth Advisors LLC 25,258$688,1550.85%
Bridge City Capital, LLC 43,485$1,184,7490.60%
View complete list of CORCEPT THERAPEUTICS INC shareholders